Tag : Sage

Pharma / Biotech

FIRST AID 4PC MINI STICK KIT (calendula flowers chamomile flowers elder flowers yarrow flowers red clover flowers sage myrrh plantain st johns wort comfrey chickweed arnica rose hip helichrysum) kit [Sierra Sage Herbs LLC]

Newsemia
Updated Date: Mon, 13 Jan 2020 00:00:00 EST Source link...
Latest News

According to THE SAGE GROUP, the Annual Economic Burden of Critical Limb Ischemia (CLI) in the U.S. Exceeds $200 Billion

Newsemia
BEAUFORT, S.C.–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24CLI&src=ctag" target="_blank">$CLI</a> <a href="https://twitter.com/hashtag/ALI?src=hash" target="_blank">#ALI</a>–The economic cost of critical limb ischemia (CLI) exceeds $200 billion. Source link...
Latest News

THE SAGE GROUP Announces Publication of U.S. Acute Limb Ischemia (ALI) Incidence and Market Estimates

Newsemia
BEAUFORT, S.C.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CLI&amp;src=ctag" target="_blank"gt;$CLIlt;/agt; lt;a href="https://twitter.com/hashtag/ALI?src=hash" target="_blank"gt;#ALIlt;/agt;–THE SAGE GROUP publishes incidence and market data on acute limb ischemia (ALI). Source link...
Latest News

Sage Therapeutics Announces FDA Advisory Committee Votes 17-1 in Support of Benefit-Risk Profile of ZULRESSO™ (brexanolone) Injection for Treatment of Postpartum Depression

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the...
Latest News

Sage Therapeutics Announces The Lancet Publishes Integrated Data from Pivotal Trials for Brexanolone Injection in Postpartum Depression

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced The Lancet...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy